{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:11:34Z","timestamp":1773231094562,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.099","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:28:27Z","timestamp":1233480507000},"page":"2156-2170","source":"Crossref","is-referenced-by-count":16,"title":["Structural organization of NadA\u0394351\u2013405, a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level"],"prefix":"10.1016","volume":"27","author":[{"given":"Claudia","family":"Magagnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bardotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Conciliis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosy","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Tomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Pennatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maruska","family":"Cerchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni L.","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Biolchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"D\u2019Ascenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Helling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2009.01.099_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/hv.4513","article-title":"Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them","volume":"3","author":"Holst","year":"2007","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2009.01.099_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"Van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.099_bib3","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.01.099_bib4","series-title":"Vaccines","first-page":"399","article-title":"Meningococcal vaccines","author":"Granoff","year":"2008"},{"key":"10.1016\/j.vaccine.2009.01.099_bib5","series-title":"Evolution of meningococcal disease","first-page":"33","author":"Vedros","year":"1987"},{"key":"10.1016\/j.vaccine.2009.01.099_bib6","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1128\/CMR.2.Suppl.S134","article-title":"Vaccines for prevention of meningococcal disease","volume":"2","author":"Frasch","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.01.099_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2009.01.099_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0002-9343(01)01072-5","article-title":"A plethora of host factors that determine the outcome of meningococcal infection","volume":"112","author":"Sparling","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2009.01.099_bib9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.01.099_bib10","doi-asserted-by":"crossref","unstructured":"Cartwright K, Noah N, Peltola H. Meningococcal disease in Europe: epidemiology, mortality and prevention with conjugate vaccines: report of a European advisory board meeting. Vienna, Austria, 6\u20138 October 2000. Vaccine 2001;19:4347\u20134356.","DOI":"10.1016\/S0264-410X(01)00205-5"},{"key":"10.1016\/j.vaccine.2009.01.099_bib11","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the U.K.: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.099_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.099_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/154.6.1033","article-title":"Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children","volume":"154","author":"Lepow","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.099_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.01.099_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis: implication for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.01.099_bib16","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.099_bib18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/171.6.1481","article-title":"Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides","volume":"171","author":"Hayrinen","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.099_bib19","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","article-title":"The concept of \u201ctailor made\u201d protein based, outer membrane vesicle vaccines against meningococcal disease","volume":"23","author":"Holst","year":"2005","journal-title":"Vaccine"},{"issue":"5459","key":"10.1016\/j.vaccine.2009.01.099_bib20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.01.099_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","article-title":"Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.099_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992\u20131998","volume":"182","author":"Sacchi","year":"2000","journal-title":"J Infect Dis"},{"issue":"29","key":"10.1016\/j.vaccine.2009.01.099_bib23","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"Universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"PNAS USA"},{"issue":"October (5645)","key":"10.1016\/j.vaccine.2009.01.099_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.1092329","article-title":"Reverse vaccinology and genomics","volume":"302","author":"Rappuoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.01.099_bib25","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.01.099_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.099_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14712598.5.12.1611","article-title":"Towards an improved serogroup B Neisseria meningitidis vaccine","volume":"5","author":"Kirsten","year":"2005","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2009.01.099_bib28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.099_bib29","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1093\/emboj\/19.22.5989","article-title":"Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins","volume":"19","author":"Hoiczyk","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2009.01.099_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/JB.182.5.1364-1373.2000","article-title":"The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro","volume":"182","author":"Lafontaine","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib31","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/JB.185.13.3735-3744.2003","article-title":"Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA","volume":"185","author":"Roggenkamp","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib32","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/MMBR.62.4.1315-1352.1998","article-title":"The virulence plasmid of Yersinia, an antihost genome","volume":"62","author":"Cornelis","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2009.01.099_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.099_bib34","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.099_bib35","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.179.6.3904","article-title":"IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A","volume":"179","author":"Mazzon","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/jmbi.1997.1069","article-title":"Role of the carboxy-terminal phenylalanine in the biogenesis of outer membrane protein PhoE of Escherichia coli K-12","volume":"269","author":"de Cock","year":"1997","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.099_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib38","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1074\/jbc.271.21.12626","article-title":"DNA binding exerted by a bacterial gene regulator with an extensive coiled coil domain","volume":"271","author":"Hurme","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.01.099_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1948029","article-title":"X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil","volume":"254","author":"O'Shea","year":"1991","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.099_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrmicro1131","article-title":"Opinion: cell entry machines: a common theme in nature?","volume":"3","author":"Barocchi","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib41","series-title":"Current protocols in protein science","year":"1997"},{"key":"10.1016\/j.vaccine.2009.01.099_bib42","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2009.01.099_bib43","series-title":"Habeck electrophoresis in practice: a guide to methods and applications of DNA and protein separations","author":"Vestermeier","year":"2005"},{"key":"10.1016\/j.vaccine.2009.01.099_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0076-6879(86)30013-2","article-title":"Calculation of protein conformation from circular dichroism","volume":"130","author":"Yang","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2009.01.099_bib45","series-title":"Derivative spectroscopy: an introduction with practical examples","author":"Schmitt","year":"1977"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.099_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"Giuliani","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.099_bib47","series-title":"Circular dichroism and the conformational analysis of biomolecules","first-page":"69","article-title":"Determination of protein secondary structure","author":"Veniaminov","year":"1996"},{"key":"10.1016\/j.vaccine.2009.01.099_bib48","series-title":"Spectrophotometry and spectrofluorimetry","first-page":"307","article-title":"Use of optical spectroscopic methods to study the thermodynamic stability of proteins","author":"Eftink","year":"2000"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.099_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abio.1996.0345","article-title":"Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions","volume":"240","author":"Wen","year":"1996","journal-title":"Anal Biochem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:56:21Z","timestamp":1684875381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":49,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001625"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}